NURS 464: Evidence-Based Nursing Capstone

Document Type

Paper

Publication Date

5-2025

Disciplines

Nursing

Abstract

Psilocybin, a naturally occurring psychedelic compound and 5-HT2A (serotonergic) receptor agonist, has recently gained attention for its potential therapeutic benefits in individuals with TRD. A landmark study published in The New England Journal of Medicine demonstrated that a single dose of psilocybin reduced depressive symptoms in patients with treatment-resistant depression, with sustained improvements noted weeks after treatment (Goodwin et al., 2022). Further, recent research involving frontline healthcare workers during the COVID-19 pandemic 3 found psilocybin therapy to be effective in alleviating symptoms of depression and burnout (Back et al., 2024). These findings suggest psilocybin therapy may offer a novel and potentially transformative approach for managing TRD, particularly in populations exposed to chronic occupational stress. This paper will explore the efficacy of psilocybin-assisted therapy as an alternative intervention for healthcare workers with TRD and will make several policy and practice recommendations to establish equitable and safe implementation in clinical practice.

Download

Included in

Nursing Commons

Share

COinS